The British Columbia Cancer Agency has agreed to reimburse for Genomic Health Inc. (NASDAQ:GHDX) Oncotype DX breast cancer recurrence test. Genomic Health, Inc. (NASDAQ:GHDX) shares after opening at $26.99 moved to $28.29 on last trade day and at the end of the day closed at $28.04. Company price to sales ratio in past twelve months was calculated as 3.34 and price to cash ratio as 8.29. Genomic Health, Inc. (NASDAQ:GHDX) showed a positive weekly performance of 5.93%.
Points International Ltd (USA) (NASDAQ:PCOM), the global leader in loyalty currency management, announced that it has purchased all of the outstanding shares of Accruity Inc., the San Francisco-based operator of the award-winning PointsHound hotel booking service. Points International Ltd (USA) (NASDAQ:PCOM) shares advanced 4.59% in last trading session and ended the day on $24.15.
Ampio Pharmaceuticals Inc. (NYSEMKT:AMPE) Monday said its wholly-owned unit Ampio Pharmaceuticals Inc. has filed for initial public offering of its common stock with the United States Securities and Exchange Commission. The company did not specify the number of shares or the estimated price range. Ampio Pharmaceuticals Inc. (NYSEMKT:AMPE) shares moved up 4.74% in last trading session and was closed at $5.74, while trading in range of $5.52 – $5.80. Ampio Pharmaceuticals Inc. (NYSEMKT:AMPE) year to date (YTD) performance is -19.50%.
TCF Financial Corporation (NYSE:TCB) Reports Quarterly Net Income of $39.9 Million, or 24 Cents Per Share, up 8 Cents, or 50 Percent, from the First Quarter of 2013. TCF Financial Corporation (NYSE:TCB) weekly performance is 4.01%. On last trading day company shares ended up $16.36. TCF Financial Corporation (NYSE:TCB) distance from 50-day simple moving average (SMA50) is 0.83%. Analysts mean target price for the company is $17.28.